Pharmaceutical Medicine and Translational Clinical Research
Editat de Divya Vohora, Gursharan Singhen Limba Engleză Paperback – 9 noi 2017
- Includes detailed coverage of current trends and key topics in pharmaceutical medicine, including biosimilars, biobetters, super generics, and
- Provides a comprehensive look at current and important aspects of the science and regulation of drug and biologics discovery
Preț: 616.35 lei
Preț vechi: 817.91 lei
-25% Nou
Puncte Express: 925
Preț estimativ în valută:
117.96€ • 122.53$ • 97.98£
117.96€ • 122.53$ • 97.98£
Carte tipărită la comandă
Livrare economică 27 ianuarie-10 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128021033
ISBN-10: 0128021039
Pagini: 526
Dimensiuni: 191 x 235 x 33 mm
Greutate: 1.13 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128021039
Pagini: 526
Dimensiuni: 191 x 235 x 33 mm
Greutate: 1.13 kg
Editura: ELSEVIER SCIENCE
Public țintă
Graduate and postgraduate students in the areas of clinical research, pharmaceutical medicine, clinical pharmacology and pharmacy, as well as professors teaching in these areas; also professionals working in the pharmaceutical industry or contract research organizations and drug regulatory authorities.Cuprins
Section I- Overview of Pharmaceutical Medicine 1. The Specialty of Pharmaceutical Medicine
Section II- Drug Discovery and Development 2. Drug Discovery and Development: An overview 3. Pharmaceutical Development 4. Preclinical Drug Development 5. Target Product Profile and Clinical Development Plan 6. Clinical Pharmacokinetics and Drug Interactions 7. Pharmacogenomics: An Evolution Towards Clinical Practice 8. Clinical Research Quality Assurance and Audits
Section III- Pharmaceutical Law and Ethics 9. Pharmaceutical Medicine and Law 10. Pharmaceutical Regulations in the United States 11. Pharmaceutical Regulations in European Union 12. Pharmaceutical Regulations in India 13. Pharmaceutical Regulations for Complementary Medicine 14. Ethical Considerations in Clinical Research
Section IV- Pharmaceutical Industry and Intellectual Property Rights 15. Patent 16. Copyright 17. Trademark 18. Trade Secret 19. Data Exclusivity
Section V- Generics, Supergenerics, Biologics, biosimilars and bio-betters 20. Generic Drug and Bioequivalence Studies 21. Vaccines 22. Biosimilars 23. Re-innovation in Pharmaceutical Industry: Supergenerics and Biobetters
Section VI- Medical Services 24. Phase IV Studies and Lifecycle Management 25. Medical Affairs
Section VII- Pharmacovigilance 26. Pharmacovigilance and Drug Safety 27. Clinical and Post Approval Safety Data Management 28. Individual Case Safety Reports 29. Development and Periodic Safety Reports 30. Risk Management in Pharmacovigilance 31. Recent Developments in Pharmacovigilance at UMC
Section VIII- Drug utilization and Pharmacoeconomics 32. Assessing Medicine Use and Tools for Monitoring Medicine Use 33. Pharmacoeconomics and Healthcare
Section II- Drug Discovery and Development 2. Drug Discovery and Development: An overview 3. Pharmaceutical Development 4. Preclinical Drug Development 5. Target Product Profile and Clinical Development Plan 6. Clinical Pharmacokinetics and Drug Interactions 7. Pharmacogenomics: An Evolution Towards Clinical Practice 8. Clinical Research Quality Assurance and Audits
Section III- Pharmaceutical Law and Ethics 9. Pharmaceutical Medicine and Law 10. Pharmaceutical Regulations in the United States 11. Pharmaceutical Regulations in European Union 12. Pharmaceutical Regulations in India 13. Pharmaceutical Regulations for Complementary Medicine 14. Ethical Considerations in Clinical Research
Section IV- Pharmaceutical Industry and Intellectual Property Rights 15. Patent 16. Copyright 17. Trademark 18. Trade Secret 19. Data Exclusivity
Section V- Generics, Supergenerics, Biologics, biosimilars and bio-betters 20. Generic Drug and Bioequivalence Studies 21. Vaccines 22. Biosimilars 23. Re-innovation in Pharmaceutical Industry: Supergenerics and Biobetters
Section VI- Medical Services 24. Phase IV Studies and Lifecycle Management 25. Medical Affairs
Section VII- Pharmacovigilance 26. Pharmacovigilance and Drug Safety 27. Clinical and Post Approval Safety Data Management 28. Individual Case Safety Reports 29. Development and Periodic Safety Reports 30. Risk Management in Pharmacovigilance 31. Recent Developments in Pharmacovigilance at UMC
Section VIII- Drug utilization and Pharmacoeconomics 32. Assessing Medicine Use and Tools for Monitoring Medicine Use 33. Pharmacoeconomics and Healthcare